Oncology & Cancer

US clears breakthrough gene therapy for childhood leukemia

Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.

Oncology & Cancer

Single-cell analysis reveals how melanoma cells resist immunotherapy

Unleashing the immune system to fight tumors—an approach enabled by immunotherapy—has led to remarkable outcomes in some cancer patients, but in many more, cancer cells evade the treatment and continue to spread. Now, ...

Medical research

Biotech startup uses nanoparticles to induce immune tolerance

More than 100 approved drugs in the U.S. warn of immune-related side effects on their labels. Countless others never make it onto shelves because of unwanted immune responses that can harm patients and limit the effectiveness ...

Oncology & Cancer

'Jumping genes' drive many cancers

Mistakes in DNA are known to drive cancer growth. But a new study, from Washington University School of Medicine in St. Louis, heavily implicates a genetic phenomenon commonly known as "jumping genes" in the growth of tumors.

Ophthalmology

Study points way forward for retinal disease gene therapy

Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes vision loss starting in childhood, improved patients' eyesight and the sensitivity of the retina within weeks of treatment. Both of these ...

Neuroscience

Scientists develop new gene therapy for eye disease

Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the ...

page 11 from 40